Federation des caisses Desjardins du Quebec’s Bristol-Myers Squibb BMY Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15M	Buy	246,938 +54,090	+28%	+$3.15M	0.05%	237
2025 Q4	$10.4M	Buy	192,848 +40,349	+26%	+$1.94M	0.04%	276
2025 Q3	$6.88M	Buy	152,499 +35,684	+31%	+$1.67M	0.03%	345
2025 Q2	$5.41M	Sell	116,815 -26,203	-18%	-$1.29M	0.02%	369
2025 Q1	$8.72M	Buy	143,018 +17,854	+14%	+$1.04M	0.04%	250
2024 Q4	$7.08M	Buy	125,164 +47,888	+62%	+$2.68M	0.04%	269
2024 Q3	$4M	Sell	77,276 -97,100	-56%	-$4.56M	0.02%	388
2024 Q2	$7.24M	Buy	174,376 +63,983	+58%	+$2.86M	0.04%	251
2024 Q1	$5.88M	Buy	110,393 +43,603	+65%	+$2.22M	0.04%	280
2023 Q4	$3.43M	Sell	66,790 -30,505	-31%	-$1.6M	0.03%	327
2023 Q3	$5.65M	Sell	97,295 -12,685	-12%	-$777K	0.06%	234
2023 Q2	$7.03M	Buy	109,980 +42,918	+64%	+$2.88M	0.07%	218
2023 Q1	$4.65M	Sell	67,062 -30,574	-31%	-$2.16M	0.05%	259
2022 Q4	$7.02M	Sell	97,636 -50,381	-34%	-$3.8M	0.08%	191
2022 Q3	$10.5M	Sell	148,017 -143,389	-49%	-$10.4M	0.13%	146
2022 Q2	$22.4M	Sell	291,406 -254,246	-47%	-$19.4M	0.25%	89
2022 Q1	$39.8M	Buy	545,652 +15,714	+3%	+$1.06M	0.39%	59
2021 Q4	$33M	Buy	529,938 +24,766	+5%	+$1.45M	0.33%	70
2021 Q3	$29.9M	Buy	505,172 +10,159	+2%	+$669K	0.31%	64
2021 Q2	$33.1M	Sell	495,013 -33,472	-6%	-$2.18M	0.33%	62
2021 Q1	$33.4M	Buy	528,485 +22,856	+5%	+$1.42M	0.37%	58
2020 Q4	$31.4M	Buy	505,629 +80,886	+19%	+$4.97M	0.38%	59
2020 Q3	$25.6M	Buy	424,743 +2,783	+0.7%	+$168K	0.36%	66
2020 Q2	$24.8M	Buy	421,960 +85,190	+25%	+$5.1M	0.37%	64
2020 Q1	$18.8M	Sell	336,770 -136,823	-29%	-$8.36M	0.33%	67
2019 Q4	$30.4M	Buy	473,593 +116,293	+33%	+$6.66M	0.43%	55
2019 Q3	$18.1M	Buy	357,300 +129,782	+57%	+$6.1M	0.26%	71
2019 Q2	$10.3M	Buy	227,518 +4,020	+2%	+$187K	0.15%	119
2019 Q1	$10.7M	Buy	223,498 +179,904	+413%	+$8.96M	0.16%	114
2018 Q4	$2.27M	Sell	43,594 -1,236	-3%	-$66.4K	0.04%	360
2018 Q3	$2.78M	Sell	44,830 -2,766	-6%	-$164K	0.04%	347
2018 Q2	$2.63M	Buy	47,596 +8,298	+21%	+$448K	0.04%	357
2018 Q1	$2.49M	Buy	39,298 +4,148	+12%	+$267K	0.04%	379
2017 Q4	$2.15M	Buy	35,150 +387	+1%	+$24.2K	0.03%	439
2017 Q3	$2.22M	Sell	34,763 -6,555	-16%	-$383K	0.04%	411
2017 Q2	$2.3M	Buy	41,318 +2,524	+7%	+$137K	0.04%	388
2017 Q1	$2.11M	Buy	+38,794	New	+$2.13M	0.04%	366

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BMY Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Bristol-Myers Squibb (BMY) stake by 28% in Q1 2026, buying an estimated $3.15M and bringing the position to 246,938 shares worth $15M. The position accounts for 0.05% of the portfolio, ranked #237.

Federation des caisses Desjardins du Quebec first reported a position in BMY in Q1 2017 and has held it in 37 quarters since. The position peaked at $39.8M in Q1 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Federation des caisses Desjardins du Quebec held 246,938 shares of Bristol-Myers Squibb worth $15M as of Q1 2026.
Federation des caisses Desjardins du Quebec bought 54,090 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.15M.
Bristol-Myers Squibb made up 0.05% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #237 holding.
Federation des caisses Desjardins du Quebec first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 37 quarters since.
Federation des caisses Desjardins du Quebec's Bristol-Myers Squibb position peaked at $39.8M in Q1 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.